Investor Presentaiton
MAX
Healthcare
Max Healthcare: Memorandum Profit & Loss Consolidation sheet of
Network Financials for H1 FY22
MHIL & its
subsidiaries &
Silos
Partner Healthcare Facilities ("PHF") Financials
(IGAAP Unaudited)*
(INR Cr)
Eliminations
&
MHC Network
(Consolidated)
Ind AS
Unaudited
Balaji
Society
GM Modi
Society
Devki Devi
Society
IND AS
Adjustment (2,6) (Certified by an
ICA)
Adjustment (1)
Revenue from operations
2,019
275
173
369
(175)
2,660
Other Income (3)
19
1
1
5
(12)
15
Total Operating income
2,037
276
174
374
(186)
2,675
Purchase of pharmacy, drugs, consumables & implants
514
53
41
117
10
735
Employee benefits expense (4)
380
38
25
38
84
565
Other expenses (5)
608
116
80
136
(285)
653
Total Expenses
1,502
207
145
292
Operating EBITDA
536
69
69
29
82
22
(2)
(191)
1,953
5
722
Less : non-operating expenses
ESOP (Equity-settled Scheme)
25
Movement in fair value of contingent consideration payable and
10
amortisation of contract assets
Exceptional costs: Provision for terminal benefits under VRS
Reported EBITDA
Finance Cost (Net)
Depreciation & Amortisation
Profit/ (Loss) before tax
Tax expenses
Profit/ (Loss) after tax
1
1
.
25
45
10
8
8
492
69
29
82
2
5
679
15
5
15
16
1
8
61
107
9
7
12
1
(15)
122
370
55
7
54
11
496
80
4
84
290
55
7
54
7
412
*Newly added PHF i.e. Vikrant Children Foundation has not been reflected separately due to negligible transactions in the entity's P&L
(1) Mainly relates to Ind AS 116 (Accounting for Leases) at PHFs | (2) Eliminations relate to amount charged to PHFs under medical service agreements and sale of pharmaceuticals etc. Also includes impact on
amortisation due to reversal of Intangible assets recognised in MHIL & its subsidiaries for contracts with PHFs. The NPV of the amount payable by a PHF to unconsolidated part of the other Society over the
contract period has been accrued under IND AS and payment there against has thus been knocked off against the liability. | (3) Other Income includes income from Clinical trials, EPCG, Unclaimed Balances written
back, Sponsorships and Contributions received, etc. | (4) Includes movement in OCI for actuarial valuation impact but excludes ESOP (Equity Settled) expenses. | (5) Net of reversal of prov. for bad debts and bad
debts recovered in current period and also excludes movement in fair value of contingent consideration and amortisation of contract assets which is considered below Operating EBITDA | (6) Some of the items
have been reclassified across line items to match with the commonly understood industry practices, e.g. forex gain/loss reclassified under Finance costs, Clinician costs reclassified under employee benefits
expense, etc.
28View entire presentation